Whole grain rye intake, reflected by a biomarker, is associated with favorable blood lipid outcomes in subjects with the metabolic syndrome--a randomized study.

Few studies have explored the possible plasma cholesterol lowering effects of rye consumption. The aim of this secondary analysis in the SYSDIET study was to investigate the association between plasma alkylresorcinols (AR), a biomarker for whole grain wheat and rye intake, and blood lipid concentrat...

Full description

Bibliographic Details
Main Authors: Ola Kally Magnusdottir, Rikard Landberg, Ingibjorg Gunnarsdottir, Lieselotte Cloetens, Björn Åkesson, Fredrik Rosqvist, Ursula Schwab, Karl-Heinz Herzig, Janne Hukkanen, Markku J Savolainen, Lea Brader, Kjeld Hermansen, Marjukka Kolehmainen, Kaisa Poutanen, Matti Uusitupa, Ulf Risérus, Inga Thorsdottir
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4207773?pdf=render